Literature DB >> 10485736

HOPE for cardiovascular disease prevention with ACE-inhibitor ramipril. Heart Outcomes Prevention Evaluation.

S Kleinert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10485736     DOI： 10.1016/s0140-6736(99)80027-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Management of hypertension. Ideal body weight is not realistic goal for lifestyle intervention.

Authors:  J Wilding; G Williams
Journal:  BMJ       Date:  2000-02-26

Review 2.  Therapeutic potential of ischaemic preconditioning.

Authors:  R J Edwards; A T Saurin; R D Rakhit; M S Marber
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

3.  Facts and ideas from anywhere.

Authors:  W C Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2000-01

4.  Enhanced angiotensin II-mediated central sympathoexcitation in streptozotocin-induced diabetes: role of superoxide anion.

Authors:  Kaushik P Patel; William G Mayhan; Keshore R Bidasee; Hong Zheng
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-11-17       Impact factor: 3.619

5.  Effect of amlodipine and lisinopril on microalbuminuria in patients with essential hypertension: A prospective study.

Authors:  S Jalal; F A Sofi; S M Abass; M S Alai; M A Bhat; H A Rather; N A Lone; M A Siddiqi
Journal:  Indian J Nephrol       Date:  2010-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.